5 Recruiting Hemophilia A Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for hemophilia a enrolling across the USA. Verify eligibility and contact site coordinators.
All Hemophilia A studiesPhase 1 / Phase 2 Studies for Hemophilia A
🔵 Active, Not Recruiting Phase1 / Phase2
Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle"
📍 Arkansas Children's Hospital - Hematology / Oncology — Little Rock, Arkansas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Gene Therapy for Haemophilia A.
📍 St. Luke'S Regional Medical Center, Ltd — Boise, Idaho
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
📍 Center for Inherited Blood Disorders — Orange, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
ASC618 Gene Therapy in Hemophilia A Patients
📍 Arkansas Children's Hospital — Little Rock, Arkansas
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
📍 UC Davis Cancer Center — Sacramento, California
View Study & Checklist ➔